Archya Dasgupta: Tata Memorial Centre, Homi Bhabha National Institute, India
Dr Dasgupta is an Assistant Professor of Radiation Oncology at Tata Memorial Centre, Mumbai, India. He completed his residency training in Radiation Oncology at Tata Memorial Centre Mumbai, following which he was a clinical research fellow at the University of Toronto with specialized experience in CNS oncology, quantitative image analysis, and ablative radiotherapy (SRS and SBRT) for brain and spine malignancies. His research interests include clinical neuro-oncology, particle beam therapy, evolutionary biology, and quantitative image analysis.
Qingtao Qiu: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China
Dr Qingtao Qiu, a medical physicist, is a senior researcher in the Department of Radiation Oncology and Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China. His area of research focuses on medical imaging processing, especially for radiomics, artificial intelligence in image segmentation, registration, and modelling. Over the past 5 years, he has published more than 40 journal articles in leading journals. His research projects have been funded by the National Natural Science Foundation of China and the Natural Science Foundation of Shandong Province. He also serves on the editorial board and as a reviewer for several professional journals.
Stefania Volpe: European Institute of Oncology (Istituto Europeo di Oncologia, IEO) IRCCS and University of Milan, Italy
Dr Volpe is a Radiation Oncologist working at the Radiation Oncology Department of the European Institute of Oncology (Istituto Europeo di Oncologia, IEO), Milan, Italy. She is currently a PhD Candidate in Computational Biology at the European School of Molecular Medicine (Scuola Europea di Medicina Molecolare, SEMM), in Milan, Italy. Her areas of reasearch include stereotactic body radiotherapy, head and neck and lung malignancies and quantitative imaging applications, with a dedicated focus on radiomics. Moreover, Dr Volpe holds the position of Principal Investigator of a 5-year prospective study on multi-omics for outcome prediction in early-stage non-small cell lung cancer candidates to curative-intent stereotactic body radiotherapy, funded by the Italian Association for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, AIRC).